Related Experiment Video

Updated: May 9, 2026

Disposable Dosators Intended for Dry Powder Delivery to Mice
04:59

Disposable Dosators Intended for Dry Powder Delivery to Mice

Published on: August 18, 2023

A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms

Anne Zajicek1, Michael J Fossler, Jeffrey S Barrett

  • 1Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA, zajiceka@mail.nih.gov.

The AAPS Journal
|August 3, 2013
PubMed

Insights

Many patients struggle with standard oral medications due to size and taste, leading to treatment failure. A task force identified key needs for developing better pediatric formulations, improving adherence and outcomes.

Area of Science:

  • Pharmaceutical Sciences
  • Pediatric Medicine
  • Regulatory Science

Background:

  • Tablets and capsules are standard oral dosage forms but pose challenges for many patients, particularly children.
  • Issues include large size, poor palatability, and incorrect dosage strength, leading to poor adherence and therapeutic failure.

Purpose of the Study:

  • To identify manufacturing, regulatory, and research needs for improved pediatric oral formulations.
  • To address challenges hindering effective medication delivery in pediatric populations.

Main Methods:

  • Formation of the American Association of Pharmaceutical Scientists' Pediatric Formulations Task Force.
  • Multidisciplinary expert review of pediatric formulation challenges, manufacturing, and regulatory considerations.

Main Results:

  • Identified critical needs including dosage form and palatability standards for all pediatric ages.
  • Highlighted requirements for relative bioavailability, small-batch manufacturing, and viable economic models.
  • Recognized the need for specific regulatory guidance for pediatric formulations.

Conclusions:

  • The assessment is a crucial initial step for developing innovative and appropriate oral formulations for children.
  • Addressing identified needs is essential for enhancing pediatric medication adherence and therapeutic success.

More Related Videos

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients11:27

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients

Published on: August 9, 2022

Related Concept Videos

Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...